NOX 0.00% 7.6¢ noxopharm limited

"Noxopharm has identified a third drug candidate as a potential...

  1. 6,848 Posts.
    lightbulb Created with Sketch. 2536
    "Noxopharm has identified a third drug candidate as a potential acquisition. This asset is owned by a private drug development company, Cardio Therapeutics Pty Ltd ACN 167 825 201 (Cardio), a company owned by Altnia Holdings Pty Ltd ACN 133 349 238 as trustee for the I. Dixon Family Trust (Altnia). Altnia is controlled by Dr. Ian Dixon, a non-executive director of Noxopharm. This asset is a small molecule drug designed to lower LDL cholesterol levels through inhibition of the PCSK9 protein, potentially offering significant advantages compared to current therapies. This drug candidate is also undergoing pre-clinical development." (25 September 2017)
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
0.000(0.00%)
Mkt cap ! $22.21M
Open High Low Value Volume
7.5¢ 7.7¢ 7.3¢ $10.34K 136.6K

Buyers (Bids)

No. Vol. Price($)
1 3392 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 48932 1
View Market Depth
Last trade - 14.24pm 09/08/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.